Gennex Laboratories Ltd share price logo

Gennex Laboratories Ltd

BSE: 531739

Small Cap

Pharma Sector

₹10.27

+0.20

(+1.99%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Gennex Laboratories shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-8%

Searches for Gennex Laboratories on INDmoney have decreased by 8% over the last 30 days.

Average holding period of indmoney investors

260 days

INDmoney investors hold Gennex Laboratories shares for an average of 260 days.

Gennex Laboratories Stock Performance

as on September 16, 2026 at 5:45 pm IST

  • Day's Low

    Day's High

    ₹10.01
    ₹10.48
    downward going graph

    2.53%

    Downside

    2.04%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹7.05
    ₹17.25
    downward going graph

    31.35%

    Downside

    67.96%

    Upside

    downward going graph

Gennex Laboratories share price movements today

Previous Close
₹10.07
Open
₹10.39
Volume
2.56L
Upper Circuit
₹12.08
Lower Circuit
₹8.06
Day's Low - High
₹10.01 - ₹10.48
52 Week Low - High
₹7.05 - ₹17.25

Gennex Laboratories Historical Returns

1 Month Return
-16.08 %
3 Month Return
-5.98 %
1 Year Return
-20.02 %
3 Year Return
+ 29.1 %
5 Year Return
+ 44.89 %

Gennex Laboratories Fundamentals

as on September 16, 2026 at 12:15 pm IST

Market Cap

₹244.65 Cr

Return on Equity (ROE)

7.9

PE Ratio (TTM)

14.15

Return on capital employed (ROCE)

10.25

Industry PE ratio

51.81

Beta (LTM)

1.44

P/B Ratio

1.53

Dividend Yield

0

PEG Ratio

-1415.38

Quarterly Earnings Growth YOY

-6.97

EPS (TTM)

0.8

Book Value

7.96

Gennex Laboratories Stock Valuation

as on September 16, 2026 at 12:15 pm IST

Gennex Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (9.03x)

March 30, 2026

Today (14.15x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (86.13x)

August 3, 2018

LowHigh

Today’s Price to Earnings Ratio: 14.15x

Gennex Laboratories Technical Analysis

Track how Gennex Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish2
Bullish9
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bullish
CCI (20)
17.32
Neutral
RSI (14)
53.5
Neutral
Momentum (10)
0
Bullish
ADI (14)
15.8
Neutral
Ultimate Oscillator (7,14,28)
55.68
Neutral

Moving Averages

Name

Value

Action

SMA (20)
10.25
Bullish
EMA (20)
10.25
Bullish
VWMA (20)
10.25
Bullish
SMA (50)
10.25
Bullish
EMA (50)
10.25
Bullish
SMA (200)
10.22
Bullish
EMA (200)
10.26
Bearish
KAMA (200)
10.26
Bearish
DEMA (200)
10.21
Bullish

Gennex Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gennex Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Gennex Laboratories Ltd image
Gennex Laboratories Ltd
NA244.658.98%0.5818137
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Gennex Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
17.58
19.14
33.5
28.32
31.55
37.71
40.33
34.18
37.24
40.37
60.96
39.84
Other Income
-
-
-
2.47
-
-
3.83
2.28
-
-
1.32
2.01
Total Income
18.18
21.4
35.52
30.79
33.38
40.01
44.16
36.45
39.3
42.96
62.27
41.85
Expenses
12.41
16.6
29.26
24.09
25.93
32.85
38.46
29.11
31.75
34.68
55.37
35.46
Operating Profit
5.17
2.54
4.24
4.23
5.62
4.86
1.87
5.07
5.49
5.69
5.59
4.38
Operating Profit Margin %
29.41%
13.27%
12.66%
14.94%
17.81%
12.89%
4.64%
14.83%
14.74%
14.09%
9.17%
10.99%
Profit Before Interest, Tax and Depreciation
5.77
4.8
6.27
6.69
7.45
7.15
5.7
7.35
7.56
8.27
6.9
6.39
Interest
0.78
0.83
0.73
0.73
0.22
0.84
1.2
0.98
1.03
1.11
1.08
0.57
Depreciation
1.03
0.45
0.23
0.45
1.11
0.5
0.54
0.5
0.47
0.52
1.16
0.9
Profit Before Tax
3.96
3.52
5.31
5.51
6.12
5.81
3.96
5.87
6.06
6.64
4.66
4.92
Tax Paid
0.89
0.75
0.81
0.85
0.75
0.75
0.88
0.85
0.55
0.65
0.21
0.25
Profit After Tax
3.07
2.76
4.5
4.66
5.37
5.07
3.07
5.02
5.51
5.99
4.46
4.67
Total Net profit including share of profit / Loss from associate company
3.07
2.76
4.5
4.66
5.37
5.07
3.07
5.02
5.51
5.99
4.46
4.67
EPS
0.16
0.16
0.16
0.19
0.21
0.22
0.14
0.22
0.21
0.22
0.16
0.19
Actual EPS
0.16
0.16
0.16
0.19
0.21
0.22
0.14
0.22
0.21
0.22
0.16
0.19
Adjusted EPS
0.16
0.16
0.16
0.19
0.21
0.22
0.14
0.22
0.21
0.22
0.16
0.19
Diluted EPS
0.16
0.16
0.14
0.19
0.21
0.22
0.14
0.21
0.21
0.22
0.16
0.19

Gennex Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
43.78
55.8
55.62
59.65
61.21
65.6
86.71
137.9
172.74
Other Income
0.91
-
1.06
-
-
-
-
-
8.25
Total Income
44.69
56.59
56.68
60.17
62.6
69.56
91.62
148.33
180.99
Expenses
41.59
51.78
52.37
53.49
55.84
60.91
69.68
121.34
150.9
Operating Profit
2.19
4.02
3.25
6.16
5.37
4.69
17.03
16.56
21.84
Operating Profit Margin %
5%
7.2%
5.84%
10.33%
8.77%
7.15%
19.64%
12.01%
12.64%
Profit Before Interest, Tax and Depreciation
3.11
4.81
4.31
6.69
6.76
8.65
21.94
27
30.08
Interest
0.73
0.98
0.75
0.74
0.88
1.35
3.08
3.61
4.2
Depreciation
0.92
0.79
1.01
0.88
0.79
0.92
2.37
1.99
2.65
Profit Before Tax
1.46
3.04
2.55
5.07
5.09
6.38
16.49
21.4
23.23
Tax Paid
0.62
0.8
0.69
1.02
1.17
1.45
3.32
3.27
2.26
Profit After Tax
0.84
2.22
1.86
4.04
3.92
4.92
13.18
18.12
20.98
Total Net profit including share of profit / Loss from associate company
0.83
2.14
1.86
4.04
3.92
4.92
13.18
18.12
20.98
EPS
0.07
0.16
0.15
0.32
0.32
0.35
0.54
0.79
0.76
Actual EPS
0.07
0.16
0.15
0.32
0.32
0.35
0.54
0.79
0.76
Adjusted EPS
0.07
0.15
0.14
0.31
0.31
0.35
0.54
0.79
0.76
Diluted EPS
0.07
0.16
0.15
0.32
0.32
0.35
0.61
0.78
0.76

Gennex Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-0.11
3.16
1.88
-1.67
-1.44
11.91
23.68
-46.69
-10.8
Cash Flow from Investing Activities
-0.97
-0.66
-0.99
-0.21
-0.03
-2.46
-38.33
18.91
0.82
Cash Flow from Financing Activities
0.86
-2.1
1.25
-0.34
1.62
-1.84
21.04
73.68
4.57
Net Cash Flow
-0.22
0.39
2.13
-2.23
0.16
7.61
6.38
45.91
-5.41

Gennex Laboratories Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Feb 2024
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Jul 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
23.6%
18.42%
18.42%
18.42%
18.42%
18.42%
18.42%
19.83%
23.62%
23.62%
23.62%
23.63%
23.63%
Public
76.39%
81.58%
81.58%
81.58%
81.58%
81.58%
81.58%
80.17%
76.38%
76.38%
76.38%
76.37%
76.37%
Total Outstanding Shares
17,74,47,674
22,74,47,674
22,74,47,674
22,74,47,674
22,74,47,674
22,74,47,674
22,74,47,674
23,14,47,674
24,29,47,674
24,29,47,674
24,29,47,674
24,29,47,674
24,29,47,674
Total Shareholders
69,723
69,750
83,996
87,820
90,236
92,506
92,326
91,183
91,183
90,320
86,306
84,133
82,886

Gennex Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Gennex Laboratories.

  • Gennex Laboratories Ltd Earnings Results

    Gennex Laboratories Ltd’s net profit fell -5.88% since last year same period to ₹4.32Cr in the Q1 2026-2027. On a quarterly growth basis, Gennex Laboratories Ltd has generated 15.51% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Gennex Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 3.74 Cr → 4.32 Cr (in ₹), with an average increase of 13.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 70.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 128.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 23.63% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 76.37% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 62.27 Cr → 41.85 Cr (in ₹), with an average decrease of 32.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, Gennex Lab. stock has moved down by -11.9%

About Gennex Laboratories Ltd

Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates. Incorporated as a private limited company on 25th June 1985, the company was converted into a public limited company in 1995. Located in Andhra Pradesh, India, its export list includes countries like Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and others. The company maintains a well-managed team at all stages of operations and has adopted GMP Good Manufacturing Practices in the year 2005-06. During 2006-07, the company installed Separate Air Handling System in final drug isolation area and also in drying and packing area to align with CGMP as per ICH/WH0 guidelines. In 2007-08, the company diversified into the business of Biotech product, while also changing its name from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited.

Revenue: ₹39.84Cr as on June 2026 (Q1 FY27)
Net Profit: ₹4.67Cr as on June 2026 (Q1 FY27)
Chairperson Name: Arihant Baid
OrganisationGennex Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOArihant Baid
E-voting on sharesClick here to vote

FAQs

What is Gennex Laboratories share price today?

Gennex Laboratories share price today stands at ₹10.27 as on . Gennex Laboratories share today touched a day high of ₹10.48 and a low of ₹10.01.

What is the 52 week high and 52 week low range for Gennex Laboratories share?

Gennex Laboratories touched a 52 week high of ₹17.25 and a 52 week low of ₹7.05. Gennex Laboratories share price today i.e. is trending at ₹10.27, which is -40.46% down from its 52 week high and 45.67% up from its 52 week low.

What is Gennex Laboratories's market capitalisation today?

Gennex Laboratories market capitalisation is ₹244.65 Cr as on .

How to buy Gennex Laboratories shares?

To buy Gennex Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 531739 or Gennex Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Gennex Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Gennex Laboratories trading volume today?

Gennex Laboratories trading volume is 2.56L as on . This means that 2.56L shares of Gennex Laboratories were bought and sold on the stock market during today's trading session.